Insmed and Ty Pennington Launch Suspect Bronchiectasis Campaign for 500,000 Patients
INSM•Insmed has launched Suspect Bronchiectasis, a collaboration with TV host Ty Pennington to boost recognition and proper diagnosis of bronchiectasis by encouraging patients with chronic cough or excess mucus to seek CT scans or pulmonologist evaluations. The campaign highlights that 500,000 Americans are diagnosed while millions remain undetected.
1. Initiative Details
Insmed introduced Suspect Bronchiectasis to elevate recognition and proper diagnosis of bronchiectasis by urging individuals with persistent cough, excess mucus or recurrent infections to consult a pulmonologist and consider CT scanning for confirmation.
2. Ty Pennington's Role
Emmy Award–winning host Ty Pennington joined Insmed based on his mother’s 40-year journey to diagnosis, using his home renovation analogy—examining foundations and walls—to underscore the need for deeper health evaluations.
3. Disease Background
Bronchiectasis widens and damages airways, hindering mucus clearance and predisposing to infections; roughly 500,000 U.S. cases are diagnosed but overlapping COPD and asthma symptoms leave millions of cases unrecognized for years.
4. Alignment with Pulmonary Strategy
This awareness campaign complements Insmed’s pulmonary portfolio, which includes two approved therapies for chronic lung diseases and mid- to late-stage investigational programs targeting serious respiratory conditions.
